Lung cancer rates lower at higher elevations
the ONA take:
According to a new study published in the journal Peerj, researchers from the University of Pennsylvania Perelman School of Medicine in Philadelphia, Pennsylvania, and the University of California Department of Biological and Medical Informatics in San Francisco, California, have found that lung cancer rates are lower at higher elevations, suggesting that atmospheric oxygen may have a role in lung carcinogenesis.
For the study, the researchers sought to investigate whether inhaled oxygen could be a carcinogen by analyzing cancer incidence rates across the Western United States.
They found that as the county elevation increased, lung cancer rates decreased. Specifically, lung cancer incidence decreased by 7.23 cases per 100,000 individuals for every 1,000-meter elevation increasing. The researchers accounted for various variables, such as smoking prevalence and education.
The authors note, however, that the observed association does not prove a causal effect between oxygen and lung cancer. They also evaluated rates of breast, colorectal, and prostate cancer, and found a weak association or no association between elevation and incidence.
The findings will probably not persuade individuals to relocate, but the identification of a universal and major risk factor for lung cancer may lead to better treatments and preventative approaches.
Lung cancer rates are lower at higher elevations, suggesting that atmospheric oxygen may have a role in lung carcinogenesis.
- Immunotherapy May Benefit Some Patients with Papillary Thyroid Carcinoma
- New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer
- Clinical Trials May Benefit Oncology Patients
- Breast Cancer Overdiagnosis Also a Result of Screening Mammography Programs
- Prostate-specific PET and CT Imaging Improves Detection of Disease and Patient Care
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Breast Cancer Diagnosis and Nurse Navigation Survey
- Novel 3D Marker Reduces Radiation, Improves Cosmesis in Breast Conserving Surgery
- Rates at Some Milestones May Indicate Clinical Trial Results for Immunotherapeutics
- Cancer Risks for BRCA1/2 Mutation Carriers Determined by Age, Family History, Mutation Location
- Long-Term Use of TPO Receptor Agonist Safe in CLL-Associated Immune Thrombocytopenia
- Savolitinib Active, Tolerable in Subset of Advanced Papillary Renal Cell Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|